BR0115262A - Derivados de amina opticamente ativos e processo de preparação destes - Google Patents

Derivados de amina opticamente ativos e processo de preparação destes

Info

Publication number
BR0115262A
BR0115262A BR0115262-9A BR0115262A BR0115262A BR 0115262 A BR0115262 A BR 0115262A BR 0115262 A BR0115262 A BR 0115262A BR 0115262 A BR0115262 A BR 0115262A
Authority
BR
Brazil
Prior art keywords
formula
optically active
represented
amino acid
amine derivatives
Prior art date
Application number
BR0115262-9A
Other languages
English (en)
Inventor
Hidetoshi Tsunoda
Kunio Okumura
Kengo Otsuka
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Publication of BR0115262A publication Critical patent/BR0115262A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"DERIVADOS DE AMINA OPTICAMENTE ATIVOS E PROCESSO DE PREPARAçãO DESTES". A presente invenção refere-se a um <244>-aminoácido facilmente disponível e barato, e é convertido em um composto representado pela fórmula (1), que é então reagido com um reagente organometálico representado pela fórmula (2) para produzir uma 5-hidroxioxazolidina opticamente ativa representada pela fórmula (3), que é então tratada com um ácido para fornecer uma aminocetona opticamente ativa representada pela fórmula (4). O produto é então convertido em um aminoálcool opticamente ativo representado pela fórmula (5) ou (6) por exemplo, por redução. Fórmula geral (4) Fórmula geral (5) Fórmula geral (6) O processo acima pode fornecer um aminoálcool opticamente ativo representado pela fórmula (5) ou (6) útil como um intermediário de produção para um medicamento ou pesticida de um <244>-aminoácido natural facilmente disponível e barato como um material de partida estereosseletivamente e estavelmente com uma pureza ótica mais elevada e um custo inferior sem racemização. Esta invenção pode também fornecer uma 5-hidroxioxazolidina opticamente ativa representada pela fórmula (3) e uma aminocetona representada pela fórmula (4) como intermediários importantes para a produção do produto acima bem como processos de preparação destes.
BR0115262-9A 2000-11-09 2001-11-09 Derivados de amina opticamente ativos e processo de preparação destes BR0115262A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000341906 2000-11-09
JP2000341767 2000-11-09
PCT/JP2001/009830 WO2002038532A1 (fr) 2000-11-09 2001-11-09 Derive d'amine optiquement actif et methode de synthese

Publications (1)

Publication Number Publication Date
BR0115262A true BR0115262A (pt) 2003-08-12

Family

ID=26603647

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115262-9A BR0115262A (pt) 2000-11-09 2001-11-09 Derivados de amina opticamente ativos e processo de preparação destes

Country Status (6)

Country Link
US (1) US7026515B2 (pt)
EP (1) EP1340743A4 (pt)
CN (1) CN1261405C (pt)
AU (1) AU2002212749A1 (pt)
BR (1) BR0115262A (pt)
WO (1) WO2002038532A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003241747A1 (en) * 2002-06-11 2003-12-22 Kaneka Corporation PROCESS FOR PRODUCING OPTICALLY ACTIVE ss-AMINO ALCOHOL
WO2006076394A2 (en) * 2005-01-11 2006-07-20 Stereotaxis, Inc. Navigation using sensed physiological data as feedback
WO2007077140A1 (de) * 2006-01-06 2007-07-12 Basf Aktiengesellschaft Hydroxy-norephedrin-derivate und verfahren zu ihrer herstellung
CN103539754B (zh) * 2012-07-16 2016-01-20 江苏万年长药业有限公司 一种4-取代-2-恶唑烷酮的环合方法
CN105693555A (zh) * 2016-03-02 2016-06-22 中山海泓药业有限公司 一种光学纯的芳烃β-氨基醇的制备方法
CN116332774A (zh) * 2023-03-29 2023-06-27 成都瑞尔医药科技有限公司 一种高手性纯度的重酒石酸间羟胺的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE254438C (pt) *
US4616014A (en) 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
JPS6229998A (ja) 1985-04-13 1987-02-07 Kanegafuchi Chem Ind Co Ltd 光学活性（ｒ）−２−ハロ−１−フエニルエタノ−ルの製造法
DE3908426A1 (de) * 1989-03-15 1990-10-31 Bayer Ag Verfahren zur stereoselektiven herstellung von optisch aktiven s,s- oder r,r-ss-aminoalkoholen
CA2014537A1 (en) * 1989-04-26 1990-10-26 Yoshio Hayashi 4-imidazoline derivatives
EP0603414B1 (en) 1992-07-01 1997-02-12 Meiji Seika Kabushiki Kaisha (-)-ritodrine
US5461147A (en) 1993-09-27 1995-10-24 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos
EP1146037B1 (en) * 1999-01-18 2006-06-21 Nippon Soda Co., Ltd. Process for the preparation of optically active amino alcohols
DE19902229C2 (de) * 1999-01-21 2000-11-02 Boehringer Ingelheim Pharma Verfahren zur Herstellung von L-Phenylephrinhydrochlorid
RU2309157C2 (ru) * 2001-12-20 2007-10-27 Уайт Производные индолилалкиламина в качестве лигандов 5-гидрокситриптамина-6
CA2496883C (en) * 2002-08-27 2011-03-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Process for the enantioselective hydrogenation of amino alcohols

Also Published As

Publication number Publication date
CN1261405C (zh) 2006-06-28
US7026515B2 (en) 2006-04-11
US20040030144A1 (en) 2004-02-12
EP1340743A4 (en) 2007-04-25
WO2002038532A1 (fr) 2002-05-16
AU2002212749A1 (en) 2002-05-21
CN1479714A (zh) 2004-03-03
EP1340743A1 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
BR0112693A (pt) (derivados) de ácido sulfonilaminometilbenzóico substituìdos e processo para preparação do mesmo
BRPI0500480A (pt) processo para a sìntese de (1s)-4,5-dimetóxi- 1-(metilaminometil)-benzociclobutano e sais de adição deste, e aplicação na sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
BR0213380A (pt) Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes
BRPI0410685A (pt) processos de purificação de 1,3-propanodiol e composições
BR0314379A (pt) Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase
BRPI0409015A (pt) processos para a preparação de 5-metil-1-r1-2-pirrolidona (iii), um produto de reação, uma composição farmacêutica, uma composição agroquìmica, uma composição de limpeza, uma composição de tinta e um lubrificante
DOP2002000512A (es) Sales de acido succinato de 5,7,14-triazatetraciclo [10.3.1.0² ¹¹.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
DE60202958D1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
DE69327567D1 (de) Verfahren zur Herstellung von Alanylglutamin
BRPI0208468B8 (pt) camsilato de amlodipina e processo para sua preparação
BR0212542A (pt) Método para a preparação de gluconato de cálcio, e, mistura de sal de glucomato/sal de ácido orgânico
BR0115262A (pt) Derivados de amina opticamente ativos e processo de preparação destes
BR0213481A (pt) Sondas
BR0012631A (pt) Processo para a preparação de compostos de amina
BRPI0409013A (pt) processos para preparação de um produto de reação, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerador ou lubrificante
BRPI0409235A (pt) processo para a produção de sal de amÈnio do ácido 2-hidróxi-4-metiltiobutìrico
ATE266618T1 (de) Verfahren zur herstellung von zwischenprodukten für pestizide
DE60233064D1 (de) Analgetisches antitumorpeptid aus skorpionen und verfahren zu dessen herstellung
ATE424195T1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
BR0209842A (pt) Processo para a preparação de imipenem
BR0214956A (pt) Processo para a preparação de derivados da [1,4,5]-oxadiazepina
BR0210512A (pt) Processo de decomposição papa o ácido (r)-(-)-2-hidroxi-2-(2-clorofenil) acético
DE60136566D1 (de) Verfahren zur herstellung von optisch aktiven 2,4-dihydrobenzofuranverbindungen
BR0113170A (pt) Processo para a preparação de dinapsolina
ATE348094T1 (de) Verfahren zur herstellung von optisch aktiven 3,7-dimethyl-6-octenol und verfahren zur herstellung von zwischenprodukt dafür

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C07D 263/04 (2006.01), C07C 213/02 (2006.01), C07C